ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
José Soliz
Matched on ORCID iD 0000-0001-9937-8035; OpenAlex author ID A5066337331. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers
Papers 3
- Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. Co-author DOI 10.1002/jso.26650↗
- Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma. First author DOI 10.1245/s10434-020-09013-4↗
- Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery. Co-author DOI 10.5812/aapm.13879↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew H. G. Katz · 3 shared papers, 2017–2021 · strength 0.30
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Paper Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas A… DOI 10.5812/aapm.13879↗
- Timothy Eric Newhook · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Naruhiko Ikoma · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Laura R. Prakash · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Michael P. Kim · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Jeffrey E. Lee · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Ching-Wei David Tzeng · 2 shared papers, 2021 · strength 0.23
- Paper Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal … DOI 10.1245/s10434-020-09013-4↗
- Paper Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therap… DOI 10.1002/jso.26650↗
- Vijaya N. R. Gottumukkala · 1 shared paper, 2017 · strength 0.06
- Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.